Related references
Note: Only part of the references are listed.Assessment of an ad hoc procedure for isolation and characterization of human albuminome
Domenica Scumaci et al.
ANALYTICAL BIOCHEMISTRY (2011)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Present and the Future
Roberta Ghidoni et al.
NEURODEGENERATIVE DISEASES (2011)
Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome
Steven E. Schutzer et al.
PLOS ONE (2011)
Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification
Carlo M. Camaggi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
The Proteomics Identifications database: 2010 update
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2010)
Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization
Hyung Jin Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Characterization of peptides and proteins in commercial HSA solutions
Marina Gay et al.
PROTEOMICS (2010)
Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid
Margareta Ramström et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis
Kevin S. Shores et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
Justin Paul et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease
Joung Wook Lee et al.
BMC NEUROLOGY (2007)
The integrity of the blood-brain barrier in Alzheimer's disease
A. Algotsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Investigation of an albumin-enriched fraction of human serum and its albuminome
Rebekah L. Gundry et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
The extraordinary ligand binding properties of human serum albumin
M Fasano et al.
IUBMB LIFE (2005)
Analysis of albumin-associated peptides and proteins from ovarian cancer patients
MS Lowenthal et al.
CLINICAL CHEMISTRY (2005)
Effective removal of albumin from serum
DA Colantonio et al.
PROTEOMICS (2005)
Differences among techniques for high-abundant protein depletion
N Zolotarjova et al.
PROTEOMICS (2005)
Increased CSF/serum albumin ratio:: a recurrent finding in violent offenders
H Anckarsäter et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis
Q Fu et al.
PROTEOMICS (2005)
Albumin: Biochemical properties and therapeutic potential
GJ Quinlan et al.
HEPATOLOGY (2005)
Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples
K Bjorhall et al.
PROTEOMICS (2005)
Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins
BA Chromy et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Heart disease, clinical proteomics and mass spectrometry
BA Stanley et al.
DISEASE MARKERS (2004)
An investigation into the human serum interactome
M Zhou et al.
ELECTROPHORESIS (2004)
Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction
NV Bhagavan et al.
CLINICAL CHEMISTRY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report
D Bar-Or et al.
JOURNAL OF EMERGENCY MEDICINE (2000)